Skip to main content

Altreno FDA Approval History

Last updated by Judith Stewart, BPharm on Aug 29, 2018.

FDA Approved: Yes (First approved August 23, 2018)
Brand name: Altreno
Generic name: tretinoin
Dosage form: Lotion
Company: Ortho Dermatologics
Treatment for: Acne

Altreno (tretinoin) is a topical retinoid for the treatment of acne.

Important information: Altreno is for use on skin only. Do not use Altreno in your eyes, mouth, the corners of your nose, or vagina.

What is Altreno?

Altreno is a prescription medicine used on the skin (topical) to treat people with acne. Acne is a condition in which the skin has blackheads, whiteheads, and other pimples.
It is not known if Altreno is safe and effective in children under 9 years of age.

Before using Altreno, tell your healthcare provider about all your medical conditions, including if you:

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

How should I use Altreno?

What should I avoid while using Altreno?

What are the possible side effects of Altreno?
Altreno may cause serious side effects, including:

These are not all the possible side effects of Altreno. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store Altreno?

Keep all medicines out of the reach of children and pets.

What are the ingredients in Altreno?

Active ingredient: tretinoin
Inactive ingredients: benzyl alcohol, butylated hydroxytoluene, carbomer copolymer type B (Pemulen TR-1), carbomer homopolymer type A (Carbopol 981), glycerin, methylparaben, mineral oil, octoxynol-9, purified water, sodium hyaluronate, soluble collagen and trolamine.

Development timeline for Altreno

DateArticle
Aug 24, 2018Approval Ortho Dermatologics Receives FDA Approval for Altreno (tretinoin 0.05%) Lotion For Acne
Jan 12, 2018Ortho Dermatologics Announces U.S. FDA Filing Acceptance For IDP-121 Acne Treatment In Lotion Form

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.